427
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

The Suppressive Effect of β-Glucan on the Production of Tumor Necrosis Factor-Alpha in BV2 Microglial Cells

, , , , , , & show all
Pages 1360-1364 | Received 27 Oct 2006, Accepted 12 Mar 2007, Published online: 22 May 2014

  • 1) Carrow, D. J., β-1,3-Glucan as a primary immune activator. Townsend Lett., 8, 86–91 (1996).
  • 2) Brown, G. D., and Gordon, S., Fungal β-glucans and mammalian immunity. Immunity, 19, 311–315 (2003).
  • 3) Nakagawa, Y., Ohno, N., and Murai, T., Supression by candida albicans β-glucan of cytokine release from activated human monocytes and from T cells in the presence of monocytes. J. Infect. Dis., 187, 710–713 (2003).
  • 4) Nameda, S., Saito, M., Miura, N. N., Adachi, Y., and Ohno, N., Effect of nitric oxide on beta-glucan/indomethacin-induced septic shock. Biol. Pharm. Bull., 28, 1254–1258 (2005).
  • 5) Hashimoto, T., Ohno, N., Adachi, Y., and Yadomae, T., Enhanced production of inducible nitric oxide synthase by β-glucans in mice. FEMS Immunol. Med. Microbiol., 19, 131–135 (1997).
  • 6) Wei, D., Williams, D., and Browder, W., Activation of AP-1 and SP1 correlates with wound growth factor gene expression in glucan-treated human fibroblasts. Int. Immunopharmacol., 2, 1163–1172 (2002).
  • 7) Delatte, S. J., Evans, J., Hebra, A., Adamson, W., Othersen, H. B., and Tagge, E. P., Effectiveness of beta-glucan collagen for treatment of partial-thickness burns in children. J. Pediatr. Surg., 36, 113–118 (2001).
  • 8) Diluzio, N. R., and Williams, D. L., Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice. Infect. Immun., 20, 804–810 (1978).
  • 9) Gonzalez-Scarano, F., and Baltuch, G., Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci., 22, 219–240 (1999).
  • 10) Nakajima, K., and Kohsaka, S., Microglia: activation and their significance in the central nervous system. J. Biochem. (Tokyo), 130, 169–175 (2001).
  • 11) Czlonkowska, A., Kurkowska-Jastrzebska, I., Czlonkowski, A., Peter, D., and Stefano, G. B., Immune processes in the pathogenesis of Parkinson’s disease: a potential role for microglia and nitric oxide. Med. Sci. Monit., 8, RA165–177 (2002).
  • 12) Barone, F. C., Arvin, B., White, R. F., Miller, A., Webb, C. L., Willette, R. N., Lysko, P. G., and Feuerstein, G. Z., Tumor necrosis factor-alpha: a mediator of focal ischemic brain injury. Stroke, 28, 1233–1244 (1997).
  • 13) Kuprash, D. V., Udalova, I. A., Turetskaya, R. L., Rice, N. R., and Nedospasov, S. A., Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene, 11, 97–106 (1995).
  • 14) Czop, J. K., and Austen, K. F., Properties of glycans that activate the human alternate complement pathway and interact with human monocytes beta glucan receptors. J. Immunol., 135, 3388–3393 (1985).
  • 15) Thornton, B. P., Vetvicka, V., Pitman, M., Goldman, R. C., and Ross, G. D., β-Glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol., 156, 1235–1246 (1996).
  • 16) Kidd, P. M., The use of mushroom glucans and proteoglycans in cancer treatment. Altern. Med. Rev., 5, 4–27 (2000).
  • 17) Kataoka, K., Muta, T., Yamazaki, S., and Takeshige, K., Activation of macrophages by linear (1→3)-B-D-glucans: implications for the recognition of fungi by innate immunity. J. Biol. Chem., 277, 36825–36831 (2002).
  • 18) Czop, J. K., and Kay, J., Isolation and characterization of beta-glucan receptors on human mononuclear phagocytes. J. Exp. Med., 173, 1511–1520 (1991).
  • 19) Sener, G., Toklu, H., Ercan, F., and Erkanli, G., Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis. Int. Immunopharmacol., 5, 1387–1396 (2005).
  • 20) Brennan, F. M., Maini, R. N., and Feldmann, M., Cytokine expression in chronic inflammatory disease. Br. Med. Bull., 51, 368–384 (1995).
  • 21) Siebenlist, U., Franzoso, G., and Brown, K., Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol., 10, 405–455 (1994).
  • 22) Read, M. A., Whitley, M. Z., Williams, A. J., and Collins, T., NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J. Exp. Med., 179, 503–512 (1994).
  • 23) Williams, D. L., Ha, T., Li, C., Kalbfleisch, J. H., Laffan, J. J., and Ferguson, D. A., Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1-3)-β-D-glucan increases long-term survival in polymicrobial sepsis. Surgery, 126, 54–65 (1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.